Skip to main content
Veterinary Medicines

AMMINOFARMA L 20%, 200 mg/ml, soluzione per uso orale per vitelli da latte, suini, polli, tacchini e conigli

Authorised
  • Paromomycin sulfate

Product identification

Medicine name:
AMMINOFARMA L 20%, 200 mg/ml, soluzione per uso orale per vitelli da latte, suini, polli, tacchini e conigli
Active substance:
  • Paromomycin sulfate
Target species:
  • Pig
  • Chicken
  • Turkey
  • Rabbit
  • Cattle (calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Paromomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        44
        day
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        2
        day
    • Turkey
      • Meat and offal
        2
        day
    • Rabbit
      • Meat and offal
        3
        day
    • Cattle (calf)
      • Meat and offal
        44
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA06
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Salute Animale S.p.A.
  • Vetem S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102519
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 8/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."